A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics.

World Allergy Organ J · 2023 · PMC9958493 · PMID 36852411

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a statistical trendp = 0.054so close (0.05 < p ≤ 0.1)

It is of notice that benralizumab showed a statistical trend p = 0.054.

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.